Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 21, 2011
Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapyNikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 11, 2013
Diagnostic relevance of plasma DNA and DNA integrity for breast cancerOliver J Stötzer, Julia Lehner, Debora Fersching-Gierlich, et al.Clinical Chemistry and Laboratory Medicine|February 27, 2015
Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000Mathias Bruegel, Dorothea Nagel, Manuela Funk, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 26, 2006
Nucleosomes in colorectal cancer patients during radiochemotherapyAndreas Kremer, Stefan Holdenrieder, Petra Stieber, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 10, 2005
Nucleosomes in pancreatic cancer patients during radiochemotherapyAndreas Kremer, Ralf Wilkowski, Stefan Holdenrieder, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancerDorit Di Gioia, Marie Dresse, Doris Mayr, et al.International Journal of Cancer|August 12, 2005
Soluble MICA in malignant diseasesStefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.Cancer Immunology, Immunotherapy : CII|April 26, 2006
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICAStefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.International Journal of Cancer|June 5, 2013
Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapyChristin Wittwer, Stefan Boeck, Volker Heinemann, et al.Anticancer Research|July 26, 2007
Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patientsDorit Laessig, Dorothea Nagel, Volker Heinemann, et al.Pageof 8